Skip to content
DVADaVita

What Is DVA Fair Value?

DaVita (DVA) fair value estimate using multiple valuation models, updated daily.

As of August 30, 2026, DaVita (DVA) has a composite fair value estimate of $1,542.40 based on four valuation models: DCF (58% weight), Graham Number (0% weight), PEG (42% weight), and DDM (0% weight). The current market price is $180.68, suggesting the stock is undervalued by 753.7%.

Data as of August 30, 2026 (today)

Composite Fair Value

Undervalued2 of 4 models

$1,542.40

vs. current price of $180.68(+753.7%)

Undervalued$1,542.40Overvalued
$180.68

How Is DVA Fair Value Calculated?

Four independent models estimate what DVA is worth. Each uses different inputs and assumptions. The composite blends them by weight.

DVA Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

58% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$2,004.55

+1009.4%

Undervalued

Inputs used

FCF: 1BGrowth: 25.0%Discount: 6%

DDM (Dividend Discount Model)

0% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

N/A

This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.

DVA Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

0% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

N/A

Requires positive EPS and book value. DaVita currently has negative earnings, so the Graham formula cannot be applied.

Inputs used

EPS: $14.85Book Value: -$11.96

PEG (Price/Earnings to Growth)

42% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$400.16

+121.5%

Undervalued

Inputs used

EPS: $14.85Growth: 27.0%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$2004.55Undervalued

Current price $180.68 is 1009.4% below this estimate

CheapFair ValueExpensive
25.0%
0.0%30.0%
6.4%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$1.30B$1.22B
Year 2$1.63B$1.44B
Year 3$2.04B$1.69B
Year 4$2.55B$1.98B
Year 5$3.18B$2.33B
Year 6$3.98B$2.74B
Year 7$4.97B$3.21B
Year 8$6.21B$3.78B
Year 9$7.77B$4.43B
Year 10$9.71B$5.21B
Terminal Value$253.57B$136.05B

What Are DVA's Key Financial Metrics?

Earnings & Growth

Current Price

$180.68

EPS (TTM)

$11.80

Forward P/E

10.5

Profit Margin

6.0%

Cash & Balance Sheet

Free Cash Flow

1B

EBITDA

2.8B

Book Value

-$11.96

Total Debt

13.4B

What Do Analysts Say About DVA?

Low

$165.00

Average

$218.43

High

$270.00

Upside

+20.9%

Current $180.68Avg Target $218.43Buy7 analysts

DVA Fair Value FAQ

What is the fair value of DVA?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), DVA's estimated fair value is $1,542.40. The stock is currently trading at $180.68, which makes it undervalued by our analysis.

How is DVA's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is DVA overvalued or undervalued?

Based on our analysis, DVA is undervalued. The current price of $180.68 is 753.7% below our estimated fair value of $1,542.40.

What do Wall Street analysts say about DVA?

7 analysts cover DaVita with a consensus rating of "Buy." The average price target is $218.43, ranging from $165.00 to $270.00. This implies 20.9% upside from the current price.